🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 05/09/2007 | 0,3626 USD |
| 06/06/2007 | 0,3626 USD |
| 07/03/2007 | 0,3626 USD |
| 06/12/2006 | 0,3626 USD |
| 30/08/2006 | 0,3626 USD |
| 31/05/2006 | 0,3626 USD |
| 08/03/2006 | 0,3626 USD |
| 30/11/2005 | 0,3626 USD |
| 31/08/2005 | 0,3626 USD |
| 01/06/2005 | 0,3626 USD |
| 02/03/2005 | 0,3626 USD |
| 01/12/2004 | 0,3626 USD |
| 01/09/2004 | 0,3626 USD |
| 02/06/2004 | 0,3531 USD |
| 03/03/2004 | 0,3531 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/09/2017 | 62,83 | 62,91 | 62,52 | 62,60 | -0,29% | 0,62% | 6.255.198 |
| 20/09/2017 | 63,04 | 63,27 | 62,20 | 62,78 | -0,24% | 1,70% | 9.903.600 |
| 19/09/2017 | 63,00 | 63,13 | 62,67 | 62,93 | -0,06% | 0,73% | 7.345.746 |
| 18/09/2017 | 63,00 | 63,37 | 62,80 | 62,97 | -0,26% | 0,91% | 11.049.274 |
| 15/09/2017 | 63,14 | 63,34 | 62,74 | 63,13 | +0,06% | 0,95% | 15.390.718 |
| 14/09/2017 | 62,01 | 63,14 | 61,94 | 63,09 | +1,02% | 1,94% | 10.437.137 |
| 13/09/2017 | 62,37 | 62,55 | 62,31 | 62,45 | -0,02% | 0,38% | 5.898.878 |
| 12/09/2017 | 62,14 | 62,61 | 62,14 | 62,46 | +0,51% | 0,77% | 7.707.202 |
| 11/09/2017 | 61,97 | 62,32 | 61,72 | 62,15 | +1,34% | 0,97% | 10.785.597 |
| 08/09/2017 | 61,06 | 61,57 | 61,01 | 61,33 | -0,08% | 0,92% | 7.719.358 |
| 07/09/2017 | 61,15 | 61,47 | 60,87 | 61,37 | +0,50% | 0,98% | 7.185.507 |
| 06/09/2017 | 60,96 | 61,38 | 60,85 | 61,07 | +0,60% | 0,88% | 7.491.838 |
| 05/09/2017 | 60,83 | 61,17 | 60,55 | 60,71 | -0,33% | 1,02% | 7.583.538 |
| 01/09/2017 | 60,87 | 61,16 | 60,69 | 60,91 | -0,05% | 0,78% | 6.481.985 |
| 31/08/2017 | 60,45 | 60,99 | 60,07 | 60,94 | +1,17% | 1,53% | 13.522.344 |
| 30/08/2017 | 60,25 | 60,28 | 60,02 | 60,23 | +0,00% | 0,43% | 5.263.580 |
| 29/08/2017 | 60,24 | 60,31 | 59,85 | 60,23 | -0,32% | 0,78% | 6.879.806 |
| 28/08/2017 | 60,22 | 60,55 | 60,10 | 60,42 | +0,60% | 0,76% | 7.858.114 |
| 25/08/2017 | 59,99 | 60,39 | 59,90 | 60,06 | +0,37% | 0,83% | 5.528.095 |
| 24/08/2017 | 59,40 | 60,03 | 59,34 | 59,84 | +0,90% | 1,16% | 8.122.105 |
| 23/08/2017 | 59,40 | 59,73 | 59,30 | 59,30 | -0,43% | 0,72% | 6.743.775 |
| 22/08/2017 | 59,13 | 59,64 | 59,08 | 59,56 | +0,73% | 0,94% | 5.779.930 |
| 21/08/2017 | 58,66 | 59,20 | 58,62 | 59,13 | +0,78% | 0,99% | 7.542.666 |
| 18/08/2017 | 58,94 | 58,99 | 58,36 | 58,67 | -0,57% | 1,07% | 8.825.942 |
| 17/08/2017 | 59,88 | 60,13 | 58,98 | 59,01 | -1,37% | 1,93% | 9.589.305 |
| 16/08/2017 | 59,57 | 60,05 | 59,48 | 59,83 | +0,32% | 0,96% | 6.352.138 |
| 15/08/2017 | 59,86 | 60,14 | 59,63 | 59,64 | -0,27% | 0,86% | 6.619.168 |
| 14/08/2017 | 60,03 | 60,11 | 59,72 | 59,80 | +0,46% | 0,65% | 5.771.860 |
| 11/08/2017 | 59,56 | 60,08 | 59,41 | 59,52 | +0,32% | 1,12% | 6.341.448 |
| 10/08/2017 | 59,51 | 59,71 | 59,32 | 59,33 | -0,50% | 0,66% | 8.137.825 |